Charleston, South Carolina, August 12, 2026
Salus Scientific announced the launch of its Clinical Insights Series, a new publication initiative focused on real-world clinical experience, implementation lessons, and emerging evidence for occupational radiation protection in procedural medicine. The inaugural publication presents findings from the first prospective formative clinical evaluation of AeroShield™ Enhanced Radiation Protection Device (ERPD) at Tallahassee Memorial Healthcare. The initiative aims to provide physicians, radiation safety professionals, hospital administrators, and procedural teams with practical evidence on the performance and clinical integration of enhanced radiation protection technologies.
AeroShield Demonstrates Low Occupational Radiation Exposure
The inaugural evaluation was a prospective observational assessment of 61 consecutive fluoroscopically guided procedures conducted at Tallahassee Memorial Healthcare under the direction of William Dixon, MD. The evaluation examined AeroShield’s performance across multiple procedure types while measuring occupational radiation exposure at four clinical staff positions. According to Salus Scientific, the assessment demonstrated low occupational radiation exposure per procedure, with average normalized doses of 0.83 mrem per case for the primary operator, 0.23 mrem for the scrub technologist, and 0.09 mrem for the sedation nurse outside the lead aprons. The company reported that these findings were statistically significant, with p<0.001. The evaluation included procedures such as diagnostic coronary angiography, percutaneous coronary intervention (PCI), right heart catheterization, and peripheral interventions, providing early evidence across a range of fluoroscopy-guided clinical environments.
Clinical Workflow Integration Supports Routine Use
Beyond radiation exposure measurements, the Clinical Insights Series emphasizes procedural versatility and workflow integration as important factors when evaluating enhanced radiation protection devices. AeroShield achieved 100% procedural utilization throughout the 61 evaluated procedures, remaining in place during every case. Salus Scientific reported that clinical teams experienced minimal impact on patient preparation, room turnover, and procedural access. The team also reportedly achieved proficiency with the technology after approximately one to two procedures, suggesting that integration into established procedural workflows can occur rapidly. These observations form part of Salus Scientific’s broader effort to evaluate radiation protection technology using practical clinical endpoints rather than focusing exclusively on percentage reductions in radiation exposure.
Advertisement
Clinical Insights Series Expands Real-World Evidence
Salus Scientific developed the Clinical Insights Series to help bridge the gap between scientific research and day-to-day clinical practice. Rather than evaluating enhanced radiation protection devices solely through traditional laboratory or exposure-reduction measures, the initiative emphasizes occupational dose per procedure, procedural versatility, and workflow integration. These measures are intended to provide hospitals and clinical teams with information that can help assess how radiation protection technologies perform under routine clinical conditions. The company plans to expand the evidence-generation program with additional clinical experience from cardiovascular centers and increasingly diverse procedural environments. The first report, titled The AeroShield™ Clinical Evaluation at Tallahassee Memorial Healthcare: Early Clinical Experience and Establishing a Clinical Benchmark for Occupational Radiation Dose Per Case, represents the initial publication in the series. Salus Scientific said future editions will continue to examine the role of AeroShield in fluoroscopy laboratories and generate practical clinical evidence related to occupational radiation safety. The company’s approach places particular emphasis on technologies that can provide protection without compromising clinical workflow, reflecting the importance of consistent adoption in procedural medicine. The launch of the Clinical Insights Series highlights the growing importance of real-world evidence in medical device evaluation, particularly for technologies designed to improve occupational safety. By examining device utilization, exposure per procedure, clinical versatility, and workflow performance together, Salus Scientific aims to provide a broader framework for assessing enhanced radiation protection systems. The initial findings from Tallahassee Memorial Healthcare establish early clinical benchmarks for AeroShield and provide a foundation for further evidence generation as the company expands its multicenter clinical program.
Source: Salus Scientific press release
